Inflammatory factors, especially IL-1β, are widely considered to be a major cause of ECM metabolic disorders, and IL-1β is commonly used to establish in vitro models of OA (Fukui et al., 2003; Caramés et al., 2008). This evidence concerns the gene IL1B and Other metabolic disease.